Overall, these findings suggest that targeting the oxidative stress induced by TDP-43 expression and the translocation of Cyclin C may offer promising therapeutic avenues for ALS treatment [111]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.